Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,716 | 147 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $768.97 | 34 | $0 (2024) |
| Novo Nordisk Inc | $250.62 | 16 | $0 (2024) |
| Lilly USA, LLC | $225.95 | 17 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $168.82 | 9 | $0 (2024) |
| Amgen Inc. | $139.65 | 7 | $0 (2024) |
| Abbott Laboratories | $117.91 | 7 | $0 (2024) |
| Exact Sciences Corporation | $114.05 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $110.85 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $103.78 | 5 | $0 (2024) |
| PFIZER INC. | $94.33 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,248 | 65 | ABBVIE INC. ($266.95) |
| 2023 | $1,161 | 64 | ABBVIE INC. ($419.14) |
| 2022 | $209.33 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($46.75) |
| 2021 | $98.34 | 5 | AbbVie Inc. ($45.32) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Biological | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes Care | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Biological | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 378 | 454 | $52,147 | $13,157 |
| 2022 | 16 | 449 | 538 | $66,301 | $18,944 |
| 2021 | 11 | 328 | 423 | $35,292 | $12,080 |
| 2020 | 11 | 274 | 304 | $29,130 | $8,171 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 92 | $12,420 | $3,519 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 79 | $14,220 | $3,081 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $10,725 | $1,877 | 17.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $2,200 | $1,360 | 61.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $5,580 | $875.13 | 15.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 60 | 82 | $1,312 | $663.60 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $912.00 | $657.80 | 72.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $1,430 | $384.98 | 26.9% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 12 | 24 | $840.00 | $308.07 | 36.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 34 | $1,700 | $215.28 | 12.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $533.00 | $91.60 | 17.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 11 | $132.00 | $67.21 | 50.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 11 | 11 | $143.00 | $55.88 | 39.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $6,787 | $3,620 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 77 | $9,963 | $3,138 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 71 | $12,570 | $3,090 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $13,113 | $2,100 | 16.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 25 | $2,750 | $1,707 | 62.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 20 | $9,000 | $909.11 | 10.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 29 | $1,102 | $782.91 | 71.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 19 | 20 | $2,270 | $695.61 | 30.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 14 | 15 | $1,350 | $538.29 | 39.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,056 | $506.10 | 47.9% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 13 | 13 | $1,170 | $463.32 | 39.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $570.00 | $405.76 | 71.2% |
About Amy Rennekamp, APRN
Amy Rennekamp, APRN is a Nurse Practitioner healthcare provider based in Florence, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1982146460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Rennekamp, APRN has received a total of $2,716 in payments from pharmaceutical and medical device companies, with $1,248 received in 2024. These payments were reported across 147 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,716).
As a Medicare-enrolled provider, Rennekamp has provided services to 1,429 Medicare beneficiaries, totaling 1,719 services with total Medicare billing of $52,352. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Florence, KY
- Active Since 11/15/2016
- Last Updated 09/10/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1982146460
Products in Payments
- VRAYLAR (Drug) $576.40
- MOUNJARO (Drug) $189.51
- XIFAXAN (Drug) $168.82
- Otezla (Drug) $139.65
- UBRELVY (Drug) $130.17
- Cologuard Collection Kit (Device) $114.05
- Ozempic (Drug) $109.63
- REXULTI (Drug) $103.78
- Veozah (Drug) $92.69
- JARDIANCE (Drug) $85.60
- FREESTYLE LIBRE 3 (Device) $64.73
- ACCRUFER (Drug) $62.51
- QULIPTA (Drug) $62.40
- Wegovy (Drug) $61.45
- FREESTYLE LIBRE 2 (Device) $53.18
- QUVIVIQ (Drug) $50.36
- Rybelsus (Drug) $41.19
- NURTEC ODT (Drug) $37.56
- Kerendia (Drug) $36.65
- Auvelity (Drug) $34.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Florence
Mrs. Karen Mann-Brown, Crnp, CRNP
Nurse Practitioner — Payments: $7,778
Samantha Rickard, Fnp-Bc, Msn, FNP-BC, MSN
Nurse Practitioner — Payments: $6,831
Megan Coleman, Np, NP
Nurse Practitioner — Payments: $5,295
Mrs. Brandi Creel, Apn-C, APN-C
Nurse Practitioner — Payments: $4,721
Katie Gruen, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $4,708
Mrs. Pamela Hill, Crnp, CRNP
Nurse Practitioner — Payments: $4,625